<SEC-DOCUMENT>0001193125-15-220689.txt : 20150611
<SEC-HEADER>0001193125-15-220689.hdr.sgml : 20150611
<ACCEPTANCE-DATETIME>20150611170052
ACCESSION NUMBER:		0001193125-15-220689
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20150611
DATE AS OF CHANGE:		20150611
EFFECTIVENESS DATE:		20150611

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARCA biopharma, Inc.
		CENTRAL INDEX KEY:			0000907654
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				363855489
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-22873
		FILM NUMBER:		15926613

	BUSINESS ADDRESS:	
		STREET 1:		11080 CIRCLEPOINT ROAD
		STREET 2:		SUITE 140
		CITY:			WESTMINSTER
		STATE:			CO
		ZIP:			80020
		BUSINESS PHONE:		720-940-2200

	MAIL ADDRESS:	
		STREET 1:		11080 CIRCLEPOINT ROAD
		STREET 2:		SUITE 140
		CITY:			WESTMINSTER
		STATE:			CO
		ZIP:			80020

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUVELO INC
		DATE OF NAME CHANGE:	20030203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HYSEQ INC
		DATE OF NAME CHANGE:	19970610
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>d941610ddefa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<HTML><HEAD>
<TITLE>DEFA14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Rule
14a-101) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION REQUIRED IN PROXY STATEMENT </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A INFORMATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Proxy Statement Pursuant to Section&nbsp;14(a) of the </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Securities Exchange Act of 1934 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="60%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Filed by the Registrant</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Filed by a Party other than the Registrant</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Preliminary Proxy Statement </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Definitive Proxy Statement </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Definitive Additional Materials </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Soliciting Material Pursuant to &#167; 240.14a-12 </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARCA BIOPHARMA, INC. </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Name of Registrant as Specified In
Its Charter) </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Name of Person(s) Filing Proxy Statement if Other Than the Registrant) </P>
<P STYLE="margin-top:20pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">No fee required. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B></B>Title of each class of securities to which transaction applies: </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B></B>Aggregate number of securities to which transaction applies: </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B></B>Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the
filing fee is calculated and state how it was determined): </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B></B>Proposed maximum aggregate value of transaction: </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B></B>Total fee paid: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Fee paid previously with preliminary materials. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. </P></TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B></B>Amount Previously Paid: </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B></B>Form, Schedule or Registration Statement No.: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B></B>Filing Party: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="7%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE="font-family:Times New Roman; font-size:10pt"><B></B>Date Filed: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ARCA biopharma, Inc. a Delaware corporation (&#147;ARCA&#148; or the &#147;Company&#148;), is filing materials
contained in this Schedule 14A with the U.S. Securities and Exchange Commission (&#147;SEC&#148;) in connection with the solicitation of proxies from its stockholders in connection with its 2015 Annual Meeting of Stockholders scheduled to be held on
June&nbsp;4, 2015 which was adjourned to June&nbsp;22, 2015 at 9:00 a.m. local time at ARCA&#146;s offices at 11080 CirclePoint Road, Suite 140, Westminster, CO 80020, and at any and all future adjournments, postponements or reschedulings thereof
(the &#147;2015 Annual Meeting&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Letter to Stockholders </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attached hereto is a letter mailed to stockholders of ARCA on June&nbsp;11, 2015. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3. </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g9416101.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><I>11080 CirclePoint Road, Suite 140 </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><I>Westminster, CO 80020 </I></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><I>Phone: 720-940-2200,
Fax: 720-208-9261 </I></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">Dear ARCA Stockholder, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">We originally scheduled our annual stockholder meeting for June&nbsp;4, 2015. However, we were forced to adjourn the meeting to allow additional time
for the Company&#146;s stockholders to vote on the proposals set forth in the Company&#146;s proxy statement filed with the SEC, which is available at<A HREF="http://www.sec.gov/Archives/edgar/data/907654/000119312515129381/d895439ddef14a.htm"> <FONT
STYLE="font-family:ARIAL"><U>http://www.sec.gov/Archives/edgar/data/907654/000119312515129381/d895439ddef14a.htm </U></FONT></A><FONT STYLE="font-family:ARIAL"><U></U></FONT><FONT STYLE="font-family:ARIAL"> </FONT></P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:26pt; font-family:ARIAL" ALIGN="center"><B>PLEASE VOTE NOW! </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:26pt; font-family:ARIAL" ALIGN="center"><B>WE NEED YOUR HELP! </B></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">Please help us avoid
further adjournments, phone calls and mailings by promptly voting your shares of ARCA biopharma, Inc. The Meeting has been adjourned to Monday, June&nbsp;22, 2015, 9:00 a.m. Mountain Daylight Time, at the Company&#146;s offices at 11080 CirclePoint
Road, Suite 140, Westminster, Colorado 80020. In the meantime, you may receive a call from us soliciting your vote. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11.5pt; font-family:ARIAL"><B>It is important that you vote. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="justify">You can cast your vote electronically by logging into the website listed on the enclosed voting instruction form or by touchtone phone by calling the
toll free number on the voting instruction form and following the instructions. You can also vote by mail by returning your executed voting instruction form in the envelope provided. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11.5pt; font-family:ARIAL"><B>Remember, your vote counts. Please vote today. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4. </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g9416101.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g9416101.jpg
M_]C_X``02D9)1@`!`0$`E@"6``#_X@Q824-#7U!23T9)3$4``0$```Q(3&EN
M;P(0``!M;G1R4D="(%A96B`'S@`"``D`!@`Q``!A8W-P35-&5`````!)14,@
M<U)'0@``````````````````]M8``0````#3+4A0("``````````````````
M`````````````````````````````````````````````!%C<')T```!4```
M`#-D97-C```!A````&QW='!T```!\````!1B:W!T```"!````!1R6%E:```"
M&````!1G6%E:```"+````!1B6%E:```"0````!1D;6YD```"5````'!D;61D
M```"Q````(AV=65D```#3````(9V:65W```#U````"1L=6UI```#^````!1M
M96%S```$#````"1T96-H```$,`````QR5%)#```$/```"`QG5%)#```$/```
M"`QB5%)#```$/```"`QT97AT`````$-O<'ER:6=H="`H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0``9&5S8P`````````2<U)'0B!)14,V,3DV
M-BTR+C$``````````````!)S4D="($E%0S8Q.38V+3(N,0``````````````
M````````````````````````````````````````````````````6%E:(```
M`````/-1``$````!%LQ865H@`````````````````````%A96B````````!O
MH@``./4```.06%E:(````````&*9``"WA0``&-I865H@````````)*````^$
M``"VSV1E<V,`````````%DE%0R!H='1P.B\O=W=W+FEE8RYC:```````````
M````%DE%0R!H='1P.B\O=W=W+FEE8RYC:```````````````````````````
M``````````````````````````````````!D97-C`````````"Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92`M('-21T(`````````
M`````"Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92`M
M('-21T(`````````````````````````````9&5S8P`````````L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0``````````
M````+%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$``````````````````````````````````'9I97<``````!.D_@`47RX`
M$,\4``/MS``$$PL``UR>`````5A96B```````$P)5@!0````5Q_G;65A<P``
M```````!`````````````````````````H\````"<VEG(`````!#4E0@8W5R
M=@````````0`````!0`*``\`%``9`!X`(P`H`"T`,@`W`#L`0`!%`$H`3P!4
M`%D`7@!C`&@`;0!R`'<`?`"!`(8`BP"0`)4`F@"?`*0`J0"N`+(`MP"\`,$`
MQ@#+`-``U0#;`.``Y0#K`/``]@#[`0$!!P$-`1,!&0$?`24!*P$R`3@!/@%%
M`4P!4@%9`6`!9P%N`74!?`&#`8L!D@&:`:$!J0&Q`;D!P0')`=$!V0'A`>D!
M\@'Z`@,"#`(4`AT")@(O`C@"00)+`E0"70)G`G$">@*$`HX"F`*B`JP"M@+!
M`LL"U0+@`NL"]0,``PL#%@,A`RT#.`-#`T\#6@-F`W(#?@.*`Y8#H@.N`[H#
MQP/3`^`#[`/Y!`8$$P0@!"T$.P1(!%4$8P1Q!'X$C`2:!*@$M@3$!-,$X03P
M!/X%#04<!2L%.@5)!5@%9P5W!88%E@6F!;4%Q075!>4%]@8&!A8&)P8W!D@&
M609J!GL&C`:=!J\&P`;1!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L![\'T@?E
M!_@("P@?"#((1@A:"&X(@@B6"*H(O@C2".<(^PD0"24).@E/"60)>0F/":0)
MN@G/">4)^PH1"B<*/0I4"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI"X`+F`NP
M"\@+X0OY#!(,*@Q##%P,=0R.#*<,P`S9#/,-#0TF#4`-6@UT#8X-J0W##=X-
M^`X3#BX.20YD#G\.FPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[!`)$"800Q!A
M$'X0FQ"Y$-<0]1$3$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3
M(Q-#$V,3@Q.D$\43Y10&%"<4211J%(L4K13.%/`5$A4T%585>!6;%;T5X!8#
M%B86219L%H\6LA;6%OH7'1=!%V47B1>N%](7]Q@;&$`891B*&*\8U1CZ&2`9
M11EK&9$9MQG=&@0:*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H<`APJ'%(<>QRC
M',P<]1T>'4<=<!V9'<,=[!X6'D`>:AZ4'KX>Z1\3'SX?:1^4'[\?ZB`5($$@
M;""8(,0@\"$<(4@A=2&A(<XA^R(G(E4B@B*O(MTC"B,X(V8CE"/"(_`D'R1-
M)'PDJR3:)0DE."5H)9<EQR7W)B<F5R:')K<FZ"<8)TDG>B>K)]PH#2@_*'$H
MHBC4*08I."EK*9TIT"H"*C4J:"J;*L\K`BLV*VDKG2O1+`4L.2QN+*(LURT,
M+4$M=BVK+>$N%BY,+H(NMR[N+R0O6B^1+\<O_C`U,&PPI##;,1(Q2C&",;HQ
M\C(J,F,RFS+4,PTS1C-_,[@S\30K-&4TGC38-1,U336'-<(U_38W-G(VKC;I
M-R0W8#><-]<X%#A0.(PXR#D%.4(Y?SF\.?DZ-CIT.K(Z[SLM.VL[JCOH/"<\
M93RD/.,](CUA/:$]X#X@/F`^H#[@/R$_83^B/^)`(T!D0*9`YT$I06I!K$'N
M0C!"<D*U0O=#.D-]0\!$`T1'1(I$SD42155%FD7>1B)&9T:K1O!'-4=[1\!(
M!4A+2)%(UTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I-`DU*39--W$XE
M3FY.MT\`3TE/DT_=4"=0<5"[40914%&;4>92,5)\4L=3$U-?4ZI3]E1"5(]4
MVU4H5755PE8/5EQ6J5;W5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF6O5;15N5
M6^5<-5R&7-9=)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB
M\&-#8Y=CZV1`9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(
M:I]J]VM/:Z=K_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R
M2W*F<P%S77.X=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&
M>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$>`J($*@6N!S8(P@I*"
M](-7@[J$'82`A..%1X6KA@Z&<H;7ASN'GX@$B&F(SHDSB9F)_HIDBLJ+,(N6
MB_R,8XS*C3&-F(W_CF:.SH\VCYZ0!I!ND-:1/Y&HDA&2>I+CDTV3MI0@E(J4
M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY`
MGJZ?'9^+G_J@::#8H4>AMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF_:=NI^"H
M4JC$J3>IJ:H<JH^K`JMUJ^FL7*S0K42MN*XMKJ&O%J^+L`"P=;#JL6"QUK)+
MLL*S.+.NM"6TG+43M8JV`;9YMO"W:+?@N%FXT;E*N<*Z.[JUNRZ[I[PAO)N]
M%;V/O@J^A+[_OWJ_]<!PP.S!9\'CPE_"V\-8P]3$4<3.Q4O%R,9&QL/'0<>_
MR#W(O,DZR;G*.,JWRS;+MLPUS+7--<VUSC;.ML\WS[C0.="ZT3S1OM(_TL'3
M1-/&U$G4R]5.U='65=;8UUS7X-ADV.C9;-GQVG;:^]N`W`7<BMT0W9;>'-ZB
MWRG?K^`VX+WA1.',XE/BV^-CX^OD<^3\Y83F#>:6YQ_GJ>@RZ+SI1NG0ZEOJ
MY>MPZ_OLANT1[9SN*.ZT[T#OS/!8\.7Q<O'_\HSS&?.G]#3TPO50]=[V;?;[
M]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____VP!#``@%!@<&!0@'
M!@<)"`@)#!,,#`L+#!@1$@X3'!@='1L8&QH?(RPE'R$J(1H;)C0G*BXO,3(Q
M'B4V.C8P.BPP,3#_VP!#`0@)"0P*#!<,#!<P(!L@,#`P,#`P,#`P,#`P,#`P
M,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,##_P``1"`!L`1T#
M`2(``A$!`Q$!_\0`'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`
MM1```@$#`P($`P4%!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*Q
MP152T?`D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA9
M6F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*S
MM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ
M_\0`'P$``P$!`0$!`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#
M!`<%!`0``0)W``$"`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1
M"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI
M:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZ
MPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1
M`Q$`/P#WJ618HR\C*BJ,DDX`KG;[Q;$CE+.#S>V]CM'Y=:J^,M0,EPEE&WR1
MC=(!W)Z"N>123QTKYO'YG4IU'3I=.IWT,.I1YI'1#Q=<GI:Q_F:4^++K_GVC
M_,UCVT&]U0\!N,^E2_96`*LN&'!'H:X(X[%RU4C9T*2Z&H?%=T"1]EB'XFFG
MQ=<_\^T?ZU1N[8K<2C&,2,!^=07=N8W$9'*C!^O>B6.Q<;WD"HTGT-RS\7*7
M`N[?8/[R'/Z5T=M<174*RP2+(C="*\T="/7`-;'A+4&MM16!F_=3_+CT;M7;
M@LTFYJG6ZF=;#14>:!W-%`HKZ5'G!1111<!,THZ5Y7\:/$,UK>:;I]C</%-"
M?MDFPXP0<(#_`./$CV%>E:5>QZCIMM>P',=S$LJ_1AG^M+8=BU110>E.X@HS
M7*^,-%U_5&@ET'6CIQB0J\1R%D)Z$D<\8]*\TU_7O&_AJ_\`L6HZM,'V[U9=
MCJZ],@E<]1_GBAL=CW3-&:\6\+W/COQ8LKV.M21Q0D*\LA"+N/887)/?\JV[
MGPS\0[6,S6_B-;EP,[!(<GZ;EQ0F%CT\'-%>1>&_B?J.GWSV'BV$OL;8\RH$
MDB.<?,HX(^F#]:]8MKB.Y@CF@=9(Y%#*RG(8'H11<+$M%%5=0O[?3;62ZOIT
M@@C&6=S@#_Z]%Q%HG%)FO)=<^(FL>(-033/!5O+&7./-V`R./7!X1?<_I6CI
MWP\UC4%$GBCQ%>OGD6\$S,%_X$>/R'XT,=CTJDR*\YU'X8/%&9-!UZ_MIU^Z
M)I"03]5P1^M</K&H^,_#-X+6_P!3OXF(RCF<R)(OJI;/_P!;-%PL>_@YHK-\
M,W;7WAW3;IWWO-;1N[>K%1D_G6E1<04&BJFK7T6FZ9=7UP0(K>)I&SZ`9HN!
M:S2UY9\&?$%Q>7FJV5_*\D\["[0,V>2<2#\R#CZUZG20[6"BBBG<1YWKP)UJ
M[]=_]*9:(0V0`P[@]ZFUC(UR[()'[SM5BR\IB!-&1G^-,`_D>/Y5\/.//B))
M]V>PG:"]"PMANB$L7S1G@^J>QK2DL/.>VG1<B0@OQT/<U):Q)90O<I,KP!3O
M!&#],54ANYKM_O&.//RHG``KU8PITDE-:LY7.4WIT+;6*M?2S2*?+0E^1P>_
M^-936C2AIY3MCZLW<D^GJ:WHXI$C)#%ACE6.0:BO8!<HK&18H5'0]C6]3#QF
MKI:[V(C-IG)7:;F^08`Z#TJM:`K?0,#@B5/SR/\`"MB^6"($1*TG^T_^'^-9
M<8/VR'/_`#U3^=>#./)56O4[XRYHL])'2B@=**^YZ'BA3)I4BC>21@J("S,>
M@`[T^N*^+>KM8>&6LH`6N=3<6R*#SM/WOTX_X$*`/+/%2WFL1S^*I_\`CVN[
MU[>,8Y5%4;#GTP"/J#7HWP5U87?AV739#^]L)3M]T?)'Z[OTK0U7PJO_``K5
M]"@1?.AM@R$#K,OSD_BV?SKS3X5:L=*\86R.VV&]'V9P>F2<I_X\`/QI%'OM
M%)FEIDA7CWQX'_$WTL_],'_]"'^)KV&O'_CQ_P`A72_^N#_^AK0]AK<WO@9_
MR*]W_P!?C?\`H"5Z">E>?_`[CPO=_P#7XW_HM*]`)XI('N>)_&RS2W\4V]S&
MNTW5L&?'=E8KG\MOY5U?P1U"2Z\-W%I)R+.X*1\]%8!L?GN_,5QOQ@U%-2\7
MK;VS>9]DB6W(7YLR$EB!CO\`,HKT;X8>'I?#WAQ$NUV7=T_GS)_<.``OX`?G
MFCJ-['5R,J(6<A5`R2>PKP'Q[XHG\5ZUY5J6:PB?9;1+G,A/&_']X]O0?C7J
M?Q8U%].\%W0B<H]TRVP(/.&^]_XZ&KR_X4:>FH>-K7S1O6V5[D@]RH`!_!F4
MTWV$NYZOX"\+0^&M(5653?S`-<RCG+==H_V03^/7J:Z84`"EH$%8GB_P]!XC
MT2>RG5?-P7@D(_U<@'!_H?8FMN@\T`<Q\,A<IX*T^"]AD@G@#Q,DB%2`'..#
M[8YKIZ0*!TI:`"N!^*=U+?-IGABR_P!?JDX,A_NQJ0<D>F>?^`FN]8XZUYSX
M,;_A)?'^K>(6;?;6:_9;7T[C(_`$_P#`Z!H\X\+7TWAGQA;2W&(S;3F&XSTV
MY*O_`%/X"OHU2".*\)^+^E#3_%<ERF?*OT$PXP-WW7'Y@'_@5>C?"C79=:\,
M(MTV^XLF\AV/5@`"I_(X_`TD-]SL:*2EIDG`:MM&M7>Y2<2'HV.U6[![8`;H
M)/PE_P#K52U@YUJ[Y`_>=ZL64L,8&5\UO?A?RZU\6GRUYW[O\SU[7IKT-75!
M&^B3FUB9`"NYCSD;AGO5#3;A5QR.QK6LKA[N)Q.46V`*L-N`?:LJ;1;J(^98
M'SX6)V@G:P_`]:[Z\)2<:U-7TV.>FXJ\),V1?CRP,BDA>-K1GGC:1-Y(QVX%
M9MMIU\XW7(\F->6Y!;'L!FM*XF:UMHS:,&@`";2O0^]=%*=1WE-6T_K0B:6T
M3)OGM3D+!(!_UT_^L:R4*?;(MB$#S4ZMGO\`2K][<12\M'Y3GNG(/X?_`%ZS
M8QB[AP<_O4Z?6O&K23J*UMSK@K19Z2.E%`Z45]L>0(3@9->1^(/$.FW?Q4@E
MU2\$&G:-E4)5F#2@Y.``?X\<_P"Q7H_BS5QH?AV]U$D;H8SY8/=SPH_,BN2^
M$.A0_P#".R:GJ$$<]QJ$QDWRJ&)0'`Z^IW'\10,UV^)'A$X_XFZ_]^)?_B:\
M1\0-9)X@NY-&N1+:^<98)`"N,\@8(!XR1^%?1_\`9>GY_P"/&V_[]+_A7F?Q
MMT.*&&QU2U@CC52;>78`N,Y92<?\"'XBET&MST/PQJB:UH5GJ"8'GQ`LO]UA
MPP_`@BM05YA\#=7,EE>:/(^3`PGB'^RW##\#@_\``J].H$Q:\?\`CS_R%=+_
M`.N#_P#H2UZ_7D'QY_Y"NE_]<'_]"6CH"W&_#-?%/]AW+^''TU;87!W1W08L
M7V+T('3&*S/$WCKQA%-/IE^ZZ;*GRR+!'M;GIALDX/8@UV?P.Y\+W>?^?QO_
M`$6E.^+OAG^U-).J6L8-U8J2XQS)%U8?4=1[9]11T'?4?\,?#_A_^S8-:T]'
MN;N0?/+<'<T4G\2@=%.>_4C!SS7>#@"O!OA?XI_X1[6?L]T^+"\(20D\1OV?
M^A]OI7O*\@=Z!-'G/QV#GP[8$9V?;/F^OEOC^M<W\#64>*[M3P?L38S_`+Z5
MW_Q4TQ]3\&7:Q+NDMB+E1_N_>_\`'2U>3_#+5%TKQI9/*=L5QFW8]AO&!^&X
M+0/H?0=+2+S2TR0HHI#TH`6BJJW]L][)91SQO<QH)'B#?,JGH2/2K)/%`',?
M$S6CHOA2YDC?9/<?Z/">^YNI'T4,?KBN:^'WBSPIX?\`#%M:3ZFD=R^9IP(I
M&PY[9"X.!@?A4/C%_P#A*OB5IN@KS:V/SS^_\;C_`+Y"K]2:]'&EZ?G_`(\;
M;_OTO^%`^AY=\5/$?AOQ%HT']FZ@LU[;2[D7RI%)0\,`2N/[I_X#65\&]7_L
M_P`4FRD?$6H)L`Z#>N2OZ;A^->P7^AZ;>6<UM)96ZI-&T;%8E!`(QQQ7SK+'
M>>']>\MP%O+"<'YN!N4Y!^A`S^-&PT?38Z4M5-)O8]1TRVO8<^7<QK*N>H!&
M:M9IW)///$2LFM761C+Y'N,5%:N,Y<X4=371^+=)>ZQ>6R[G4;74#DCU%<B&
M(Z=J^(QM&5&N[[-W/8H24Z:-Y;TR!5`PB\*@_P`]:TI+P+-#$K#;`0OU;C-<
MS;W'E,'R<CD?6I%N#[^U.GC)17J*5%,Z5]06+49M[8C+%&^G3/\`*LR2Y>WE
MD3.<91E/1OK5"XN]T\K9^\Q//N:AGN?,PQ/S8P?PJJF,<MNX0HI=!]Y(,ED)
MVGH#U%06"M+?VRKU,JC]?\,U`[YZGBNF\):._G"^N%*J!^[!_B]ZSPU&>(K*
MQ=64:<'<ZT4$X!HKG?$]CXFO9PFA:I:V%L8P&+Q%I-V><'H!C'O7VQXIQ7Q>
MU4ZGJMAX:L70OYJ-*<\!V.U%/X$D_45Z?IUM%8V-O9P`B*WC6),^@&!_*O+7
M^$.I23-/)KL;3LV\R-"Q);USNZUVOAS3_%-E=HNLZM:WUHJ$86+;(3Q@YP*8
MSI:Q?&>E_P!L^&K^R'WWB+1G'\:_,OZ@5LGVKC]?T;Q?J<]U%:ZY:6=E*Q"*
MD1\P)Z$XZ_2D(\C\"ZTN@^)[.]E)%ODQS8/\##!/X<'\*^BHI%EC1XV#*PR&
M4Y!_&O)1\'+SOK$'T\AO\:V]$\)>,=!A%OIWB&U>V4Y6*>(LH^G!('L"*93U
M/0CQ7COQVD5M7TU`>5MV)_%^/Y&O1/$EIXDNGA&@ZC:6484B4S1;V)[8X(QU
MKA[_`.%>L:I=/=:EK\<\[]7:-F_#J,#VI`C4^!SK_P`(W>IG+"\)(^J)BO03
MTZ9KS'1_AQXBT&X,^C>(H8'88<&$[7^H)(/Y5W?AV+6(;)DUVZM[JXWG$D";
M1MP,`CUSF@3/%/B7X8/AW76:!2MC>$R0>B_WD_`GCVQZ5WWPD\6#5=-72;^7
M-[9J!&SGF6/M^(Z?3!]:Z;QEX>A\2Z'+82;5D^_#(1_JY!T/TZ@^QKSZU^$6
MJ02)-'K4$$R$%6BC;*GU!R*=A[GK3@.N.H/K7@OQ#\'3>&M2:XM$<Z7.V8G7
MGR2?X">WL?3W%>I^'],\6:?>1+JFM6U_9*I#*8L2GCC!QZXZYKH[FUAN[9X+
MF))HI%VNCC*L/<4A;'(_#7QI!K^G):7DH&IP+APW'G`?QC^H['VKM`<UYKK7
MPG@-R+KP[?R6$JG<L;DE5/\`LL/F7]:LVK_$C2E$3VVGZQ&HP)#*%8CW)*Y_
M$4PW/0<UD^)_$-CX=TN2[O9.<$11*?GE;^ZO^/:N;>\^(UZ-D.EZ7IP;CS))
M?,*_D3_(UC7?PQUS6KG[5K_B".28\$K$9,#T4$J`/;%`6+WPBDNM6N=<U^]^
M>6[F6(>@V@G`]@&0?\!KM=?U>VT32+F_NVPD"%L=V/\`"H]R>*S/#_AR7PWX
M:ETW2[H2W/SND\R87S&'!8#L./RKFM=\!^)_$3)_;'B&!D0Y2*.$A`?7''/N
M:`*WP6M6O)]7UZZ^>YGE\K>>HS\[_F2OY5ZB*\VT+P'XF\.-(=&U^W5)6#21
MR0G:Q]<'./K7H&F+=I8PKJ,D4ET%`E>)=JLW<@=A2$6J\9^..F"#6;/44`47
M<)CDP.=R$8/Y,/\`OFO4_$,6K36830KFWMKG<,O<(67;@Y''?.*X37/A]XD\
M0SI)K.OV\OE`A%6$A5SUP!CFF]1K0F^"VO1W&BR:/-)^_LV+Q*>\3'/'T)(_
M$5Z/7DUO\)=4LITN;+78X9XSE'2-D*GZ@UV6CV7BZV1TU+5+*[Z;&$15N^<X
M`'I^M)`SI\5G7NA6%X^^:`;SU925)_*M*BIG3A45I*X)N.QB#PMIO]V3_OLT
MO_"+Z;_=D_[[K:HK#ZGA_P"1&GM9]S$/A;33_#+_`-]FC_A%M-_NR?\`?9K;
MHH^IX?\`D0>VJ=S*M?#^GVL@>.`%AT+DM_.M,#`Q3J*VA3A35H*Q#DY;L***
M0]*T1(QY44#<P7)`&3U/I3P<UR>G6XOO%4\H>22&T)*F1RV&QCC/09W$?2NL
M7I1N`$XH!ILJED95;:2"`?2LW0=/NM/BE6[NC<%WW+UX&/?\Z%H!JT4F:,T[
M@+125534;9[][)9,SH-S*`<`<=^G<4DP+9II('6ESFJNK%$TZX>1I$54+$QL
M5;CG@BA@3B1#(8PREP,E<\@?2I!TKG?!-L5L);J3)DG?[Q.257C^>:Z$4(!:
M*0G%&:`%HI,TM/<`HHI,T`&*6C-)FEL`M%)FC-`"T4F:6BX!1113N`4444@"
MBBB@`HHHH`****`"J.MW@L--GN,X8+A/]X\#]35XUS/BUC=7UAIH.U97#.?;
MI_C^E`T4M%COUT:5[*18%^:629URSL!]U?H!R?4FMWPQ=SWFCQ37#%W+,NXC
MJ`<57U9C-"NC:9C<ZA)"O2&/OGW(XQ6O9VZ6EI'!$,+&,#W]Z`9B^)=2NK:V
M?[.?(`8(KE<M(QY.WV`[_E6OIJSC3X!=MNGV#>?>N<O+F._\0DN=]M8$#8!D
MR29X`'?+#_QTUU2DF,'!!QT/:@1BWFI7%WJ@TS37\LIS/-MSL'H.V>WUHL+R
M6'7YM,DF:>,('1WQN!P"02![U3\(8BL[^]N7VMYI#L>V!D_JWZ4_PU#)>:E=
M:Q(I5)B5B!'4>OY`#\Z"F;NH7#VULTL<7F$=BVT`=R3Z5RNCVMW>07VJQW36
MLSL^-BCYL<]_R_"M?QC>&VTAD7[T[",8].I_05'=LND>%TM@=TTD?DH!U9VZ
MG\R30)%CPKJ$NHZ<9+@YD1]A;&,\`@_D:K>-KOR-+$*XW3O@_P"Z.3_3\ZN^
M'-/;3M,CAD_UC'>_L3V_#I65?Q+JOBI8I2/LUBFZ3/3/!_JOY&@.HDXOX="\
MVUF%I;VZ`(FWYY!P"Q],Y)`]^U;.@7<MYI-O//CS&!W'UP2,_I5/7IEO;&*S
ML'25[MPH*$$!0<L>/IBM2"*.RL4C7B.%,?@!0#>A%?WZV[QPQ)YUU+_JX@<?
M4D]A6+JLNJ/J-K8)=JKS'>PA7;L7GODYXS^5)H^H1>1=:G.WF7,[E%B7E@`.
M%'IWS4/AJX-QJ,E_=`R7%PWEQJ.=JCEC[`9`H'8ZF>0PP,RH\K*.%7DL?2N6
M75M1&OR6XD68[=@A0?('('?T'.3[5T]Y.MM:RSR?=C4L?PK!\&V;%)=2N`3+
M<,0I/IGD_B?Y4A(O:3;ZK#>3&_N4GA(RF/7V'8=:;X@OKBUMY3;GR0B@F5ES
MDDX"J.Y]3VXK9`Q7+Z_G5M9M])B)$<?[R9O3C_`_K3!$46HZC+X=:Y:Y\A85
M)\XJ-TK9X4>GIGN:+?4M1GT)[@SB#R0VZ9DRTAR<*/T!-2:ZGVV^M-$LR8XT
M`>3`X4`<?D/U(IFN^2]Y:Z/$PBMK<"6;'`51Z_AG\32'H;7AN:YGT>&6\):1
M\D,1@E<\'\JGU"^BLXE+AG>0[8XU&6=O0"I;)Q):QLL;1*5X1A@@=JYZQOX+
MC5KZ^NI0/LQ\F%.I`SS@=R?ZTQ;BZ]=ZG;P0HMQ%'-=OM6*-.5Z?Q9YYP.G>
MN@LH7M[:.*25IF5<,[G))KE+&[:^UV6_NE.(#Y4,0.6W'.!]1R3_`(5V0H!Z
M!1110(****=@"BBBBP!11118`HHIK$@_A18!U4=1TBSU%U>ZBW.@PK*Q4C\1
M5S)W8]J,GBE8"&SLX+*+RK:)8TZ\=_<GO4]-W')YZ'_"@D@_Y]J+`5+72+*U
MN9+F&$":0Y+$DX^F>G?\ZN@8%-5B?TIYZ4[`9\FC64K.SQMB1M[H'8(S>I4'
M!J\JK&@5`%4<``8`H4DYIEQ$9HR@EDB)_BC(!'YBE8#FM25-8\40V;#=#:H6
MD!Z>I_\`91^=;EOI=K#*LP1GD484R.S[1Z#)XJM9^'H+.[-S#=W?F-]\LRG>
M.X.5]JU1]W-.PV+BJBZ7:*;DB$9N@1-R?G!S_C5E6)SGM2@G)HL(J:=I5IIR
ML+2%4W=3R2?Q-6V7<A4\@]<]Z=0>E%@,ZTT2PM%D$$`'F@JQ8DG![9/05+I^
MEVFG*1:1!-WWB3DG\35IB0.*122>M*P#+JVCNX&@G4/&XPRY/-.@A2")(HE"
M1H-J@=A3G)`XIU%@$Q5:WT^WM[B:XAB"RSG+MDY-6&)&<>E)N.<>U%@(8;"W
M@NI;F*(+--]]\GG_`#BH7TBR?4/MSPAKC`PS'('OCUJ]G^5+3L`@&*H6^BV%
MO=-<QVZ"4G=N.3@^P/3\*T**+`4++1[*QF>:VA"R/G+$DGGL,]*OT446`***
%*+`?_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
